BNF_06

We're very pleased to let you know that our e-learning course on Type 2 Diabetes, which was developed jointly with the Eastern Academic Health Science Network, has been formally endorsed by NICE.  The ...
Created on 23 May 2017
This bulletin looks at reviewing the use of hormone replacement therapy in menopause. It discusses the implementation of NICE guidance, choices of treatment and review of therapy in long term use.   Menopause ...
The controlled drugs bulletin and resources have been written to support CCG teams that have a role in supporting the regional NHS England Controlled Drugs Accountable Officer (CDAO).  An audit ...
This bulletin is an update to the oral hypoglycaemics and other antidiabetic drugs bulletin. It discusses the evidence base for the currently available antidiabetic drugs (including newer treatment agents) ...
The RCP has replaced their  statement on the diagnosis and management of primary hypothyroidism with  the 2015 ‘Management of primary hypothyroidism: statement by the British Thyroid ...
Biosimilar insulin glargine is the most recent biosimilar to become available within the NHS. This product will be of particular interest in primary care as there is significant primary care prescribing ...
This bulletin supports reviewing long term treatment with bisphosphonates and the consideration of treatment break in these patients. A patient information leaflet is available as a supporting resource.  ...
This DROP-List support bulletin looks at the place in therapy of liothyronine and combination products containing levothyroxine and liothyronine. In light of a limited evidence base supporting its use ...
Created on 06 August 2015
This bulletin updates and replaces the previously published bulletin 16 on insulin analogues.  The bulletin reviews the pace in therapy of the insulin analogues and supporting tools are ...
Created on 08 July 2015
This bulletin updates the needle section from bulletin 16, which has now been developed as a stand alone bulletin. It looks at cost effective choices of needles and also advises on the appropriate use ...
The Oral hypoglycaemic bulletin is an update of the bulletin published in 2014 and incorporates the newer agents that have been launched since the bulletin was last written. A pathway document, audit and ...
Created on 07 July 2015
This short bulletin advises on cost effective choices of lancets and highlights those costing less than £3 per 100 lancets. It also advises on the appropriate use of safety lancets.  Lancets ...
Created on 30 October 2014
The bulletin focuses on alogliptin which is the fifth dipeptidylpeptidase-4 (DPP-4) inhibitor licensed in the UK. The document includes recommendations to ensure prescribing is in line with NICE guidance, ...
Created on 14 May 2014
To ensure that the website is kept up to date and you are able to find the most recent and relevant bulletins with ease, we have now archived some of our older publications. These are still available ...
The bulletin and accompanying documents focus on appropriate prescribing of blood glucose testing strips for people with type 2 diabetes mellitus and also improving prescribing efficiencies in this ...
This is one of a number of bulletins/briefings providing further information on medicines contained in The PrescQIPP DROP-List (DRugs oflOw Priority). This bulletin focuses on gliclazide ...